Response to disease modifying therapies in African Americans with multiple sclerosis

Ethnicity and Disease

Volumn 22, Issue 2, 2012, Pages 221-225

  Klineova, Sylvia ^a   Nicholas, Joyce ^a   Walker, Aljoeson ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

African American; Difference; Disease modifying therapy; Response

Indexed keywords

NATALIZUMAB;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DISEASE DURATION; ETHNICITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AFRICAN AMERICANS; DISABILITY EVALUATION; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOUTH CAROLINA; TREATMENT OUTCOME;

EID: 84862217460     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cree BAC, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2004;63:2039-2045. (Pubitemid 39636249)
2. Kister I, Chamot E, Bacon JH, et al. Rapid disease course in African Americans with multiple sclerosis. Neurology. 2010;75:217-223.
3. Kaufman MD, Johnson SK, Moyer D, Bivens J, Norton HJ. Severity and Progression Rate in African American Compared with Whites. Am J Phys Med Rehabil. 2003;8:582-589.
4. Naismith RT, Trinkaus, Cross AH. Phenotype and prognosis in African Americans with multiple sclerosis: a retrospective chart review. Mult Scler. 2006;12:775-781. (Pubitemid 46111770)
5. Rinker JR, Trinkaus K, Naismith RT, Cross AH. Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology. 2007;69:68-72. (Pubitemid 47025207)
6. Cree BAC, Al-Sabbagh A, Bennett R, Goodin D. Response to Interferon Beta-1a Treatment in African American Multiple Sclerosis Patients. Arch Neurol. 2005;62:1681-1683. (Pubitemid 41626662)
7. Switzer PK. The incidence of sickle cell trait in Negroes from the sea-island areas of South Carolina. South Med J. 1950;43:48-49.
8. Powers B. Black Charlestonians: A Social History. Fayetteville: The University of Arkansas Press; 1994.
9. Frey WH. Census 2000 Shows Large Black Return to the South, Reinforcing the Regions White-Black Demographic Profile. Population Studies Center, University of Michigan; 2001.
10. Ames FR, Louw S. Multiple sclerosis in coloured South Africans. J Neurol Neurosurg Psychiatry. 1977;40:729-735. (Pubitemid 8203112)
11. Ames FR, Bowen RM. First coloured South African with multiple sclerosis confirmed by necropsy. J Neurol Neurosurg Psychiatry. 1972;42:731-733.
12. Pos Z, Selleri S, Spivey TL, et al. Genomic scale analysis of racial impact on response to INF-alpha. Proc Natl Acad Sci U S A. 2010;2:803-808.
13. Rozenberg L, Haagmans BL, Neuman AU, et al. Therapeutic response to peg-INF-alpha-2b and ribavirin in HIV/HCV co-infected African American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics. AIDS. 2009;23:2439-2450.
14. Buchanan RJ, Martin RA, Zuniga M, Wang S, Kim M. Nursing home residents with multiple sclerosis: comparison of African American residents to White residents at admission. Mult Scler. 2004;10:660-667. (Pubitemid 39585245)